跳至主要内容
临床试验/JPRN-jRCT1080222388
JPRN-jRCT1080222388未知Unknown

Sonias Combination Tablets special drug use surveillance Survey on long-term use in type 2 diabetes mellitus

TAKEDA PHARMACEUTICAL COMPANY LTD.0 个研究点目标入组 1,000 人开始时间: 2014年2月6日最近更新:
适应症

试验速览

阶段
Unknown
发起方
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • Patients with type 2 diabetes mellitus for whom a physician has concluded that combination therapy with pioglitazone hydrochloride and glimepiride is appropriate and for whom long-term treatment with Sonias Combination Tablets is considered necessary

排除标准

  • (1) Patients with cardiac failure or a history of cardiac failure
  • (2) Patients with serious hepatic or renal impairment
  • (3) Patients with severe ketosis, diabetic coma or precoma, or type 1 diabetes mellitus
  • (4) Patients with severe infection, severe trauma, or pre- and post-operative patients
  • (5) Patients with gastrointestinal disorders such as diarrhea and vomiting
  • (6) Pregnant or potentially pregnant women
  • (7) Patients with a history of hypersensitivity to the ingredients in Sonias Combination Tablets or sulfonamides

研究者

发起方
TAKEDA PHARMACEUTICAL COMPANY LTD.

相似试验